ScholarIQanswers from OpenAlex
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
PaperCitations, authors & open-access status
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B have?
ScholarIQcitation count
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B has 350 citations in the OpenAlex counts ScholarIQ stores.
When was Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B published?
ScholarIQyear
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B has 2023 year in the ScholarIQ index.
What is the open-access status of Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?
ScholarIQoa status
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B has bronze oa status in the ScholarIQ index.
What is the DOI of Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?
ScholarIQdoi
The DOI for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is on the source record.
What is the PMID of Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?
ScholarIQpmid
The PMID for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is on the source record.
What is the OpenAlex record for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?
ScholarIQopenalex
The OpenAlex for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is on the source record.